Study Status
Show Details
Nickname
Protocol Nickname Study Status
Active Site Activation
176 / 190 (92.6%) Participant Enrollment
1301 / 1300 (100.1%)
Protocol Row Id
1-1G9113 Studyid
AA-AA-000-0000 Protocol Title
Protocol Title Nickname
Protocol Nickname Protocol Type
Investigator Sponsored Phase
P3 Num Plan Site
190 Num Site Actl
176 Est Fpfv
2003-01-01 Act Fpfv
2003-01-01 Est Lplv
2021-06-01 Act Lplv
2021-06-01 Est Lpfv
2020-06-01 Act Lpfv
2020-06-01 Study Status
Active Num Plan Subj
1300 Num Enrolled Subj M
1301 Protocol Indication
Protocol Indication Product
Product Therapeutic Area
Therapeutic Area Protocol Product Number
123 X Rbm Flg
Y Site Target
190 Participant Target
1300 Participants Enrolled
1301 Active Participant Count
1301 Sites Enrolled
176 Percent Sites Activated
92.6 Site Activation
176 / 190 (92.6%) Percent Participants Enrolled
100.1 Participant Enrollment
1301 / 1300 (100.1%) Percent Participants Active
100 Active Participants
1301 / 1301 (100%)
Study Overview
As of 2025-01-20, AA-AA-000-0000 has 1301 participants enrolled across
176 sites. 118 Site-KRI combinations have been flagged across 72 sites
as shown in the Study Overview Table above.
37 sites have at least one red KRI
72 sites have at least one red or amber KRI
104 sites have neither red nor amber KRIs
Results
Adverse Event Rate Simaerep
Adverse Event Rate ZScore
Protocol Deviation Rate
Protocol Deviation Rate ZScore
Metric Details